SLC2A4 and Insulin resistance: Apelin was shown to suppress insulin resistance by increasing AMP-activated protein kinase (AMPK)-mediated glucose utilization and stimulating glucose transporter (Glut) 4, involved in the PI3K and Akt signaling pathways.